肺炎支原体耐药机制与早期识别的研究进展

白 娜, 燕 晋媛, 尚 晓丽
昆明医科大学第二附属医院

摘要


肺炎支原体是儿童急性呼吸道感染和肺炎的主要病原体，尤其是学龄儿童及青少年社区获得性肺炎。大环内酯类药物是目前治疗肺炎支原体肺炎的一线用药，但近年来大环内酯类药物耐药肺炎支原体检出率明显增高。本文系统综述儿童肺炎支原体耐大环内酯类药物的发生机制、临床特征及其早期识别策略，为进一步指导儿童耐大环内酯类肺炎支原体的早期识别、诊断和精准治疗提供循证医学依据。

关键词


肺炎支原体肺炎；耐药基因；儿童；大环内酯类

全文:

PDF


参考


[1]赵顺英,钱素云,陈志敏,等.儿童肺炎支原体肺炎诊疗指南(2023年版)[J].新发传染病电子杂志,2024, 9(01):73-79.

[2]Okazaki M,Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro[J]. Microbiol Immunol.2001,45(8):617-620.

[3]Shim Jung Yeon.Current perspectives on atypical pneumonia in children[J].Clinical and experimental pediatrics.2020,63(12):469-476.

[4]Jiang Yue,Dou Haiwei,Xu Bo,et al.Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019[J].Epidemiology And Infection. 2024,152:75.

[5]赵顺英,钱素云,陈志敏,等.儿童肺炎支原体肺炎诊疗指南(2023年版)[J].新发传染病电子杂志,20 24,9(1):73-79.

[6]Kim K,Jung S,Kim M.Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections:a systematic review and meta-analysis[J].JAMA Netw Open. 2022,5:947-949.

[7]Narita M, Tanaka H. Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia [J].Cytokine.2012,59:18–19.

[8]Inamura, N,Miyashita, N, Hasegawa, S,Management of refractory Mycoplasma pneumoniae pneumonia: utility ofmeasuring serum lactate dehydrogenase level[J].Infect. Chemother. 2014,20: 270–273.

[9]Jiang Ting-Ting,Sun Lin,Wang Tian-Yi,et al.The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic[J].Frontiers in cellular and infection microbiology.2023,13:118-119.

[10]Chen JY, Zhang H, Shang YX.Clinical and bronchoscopic characteristics of children with 23S rRNA resistance gene in Mycoplasma pneumoniae bronchoalveolar lavage fluid[J].Chin J ApplClin Pediatr. 2022,37:897–902.

[11]Lee E,Cho HJ,Hong SJ,Lee J,Sung H,Yu J. Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children[J].Korean J Pediatr.2017,60:151.

[12]Matsuda K, Narita M, Sera N, Maeda E, Yoshitomi H, Ohya H,et al.Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan [J].BMC Infect Dis. 2013,13:591.

[13]Wu TH, Wang NM, Liu FC, Pan HH, Huang FL, Fang YP, et al.Macrolide resistance, clinical features, and cytokine profiles in Taiwanese children with Mycoplasma pneumoniae infection[J].Open Forum Infect Dis. 2021,8: 416.

[14]Chen JY, Zhang H, Shang YX. Clinical and bronchoscopic characteristics of children with 23S rRNA resistance gene in Mycoplasma pneumoniae bronchoalveolar lavage fluid[J].Chin J Appl Clin Pediatr. 2022,37:897–902.


Refbacks

  • 当前没有refback。